Skip to main content
Supplementary Figure 4 | Arthritis Research & Therapy

Supplementary Figure 4

From: Successful immunotherapy with matrix metalloproteinase-derived peptides in adjuvant arthritis depends on the timing of peptide administration

Supplementary Figure 4

Mean body weight of rats treated nasally with matrix metalloproteinase (MMP) peptides after induction of adjuvant arthritis (AA). The mean body weight is depicted as the percentage of the body weight at the time of AA induction. Data shown are percentage body weight ± standard error of the mean of two experiments with five rats (MMP-10 and MMP-16 peptide groups) or 10 rats (MMP-3 peptide group) per group. OVA323–339, ovalbumin peptide.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us